Conclusion of a Europe-wide distribution agreement with Tomita Pharmaceutical Co.Ltd.

Our joint efforts with the Japanese manufacturer Tomita Pharmaceutical Co.Ltd. to market their FLORITE® product range, which have been ongoing for several years, have now resulted in the conclusion of a formal distribution agreement.

FLORITE® is a synthetic calcium silicate with a unique petaloid crystal structure. This enables, among other things, the absorption of large quantities of oily liquid and the processing of these in solid dosage forms (e.g. tablets). 

This distribution agreement includes the exclusive commercialisation of FLORITE® for life science applications in almost all of Europe (excluding the UK and Ireland). 

Through regulatory compliance with the actual pharmacopoeia monographs and the corresponding food additive number, we offer with FLORITE® an innovative formulation tool for solving formulation issues related to the processing of oily and poorly water-soluble substances. 

We are delighted with the trust placed in us by Tomita and are now pursuing the expansion of our Europe-wide business with this innovative excipient with great effort and enthusiasm.